Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Blackhawk growth corp - The Untold Story

Blackhawks Mindbio Therapeutics Announces Investment in Health Research Platform Quantified Citizen, a Health Technology Company Disrupting and Decentralizing Clinical Research

Vancouver, British Columbia – TheNewswire - March 15, 2022 – Blackhawk Growth Corp. (CSE:BLR); (Frankfurt:0JJ) (the "Company" or "Blackhawk") is pleased to report that MindBio Therapeutics ("MindBio") has co-invested in Quantified Citizen's (quantifiedcitizen.com) latest funding round with other notable investors around the world. The investment was funded from MindBio existing…

Benzinga · Mar 15, 2022

Blackhawks Mindbio Therapeutics Announces Acquisition Pathway to Accelerate Clinical Trials and Drug Development Activities

Benzinga · Mar 15, 2022

Blackhawk Growth Closes Investment in Stable Foods

Vancouver, British Columbia - TheNewswire - March 11, 2022 - Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the "Company" or "Blackhawk"), is pleased to announce that the Company has completed the acquisition of the remaining share capital of Stable Foods Co. (formerly known as NuWave Foods).

Benzinga · Mar 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Blackhawk Growth to Acquire Remaining 49% of NuWave Foods; NuWave Foods Changes Name to Stable Foods

Vancouver, British Columbia - TheNewswire - February 28, 2022- Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt: 0JJ) (the "Company" or "Blackhawk"), is pleased to announce that it has entered into a definitive share purchase agreement (the "Purchase Agreement") pursuant to which it intends to acquire (the "Acquisition") the remaining 49%…

Benzinga · Feb 28, 2022

Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website

Vancouver, British Columbia – TheNewswire - February 3, 2022 – Blackhawk Growth Corp. (CSE:BLR); (CSE:BLR); (OTC:BLRZF); (Frankfurt:0JJ) (the "Company" or "Blackhawk") is pleased to announce that it has published its recent investor presentation and QA event on their website here: https://www.blackhawkgrowth.com/investors/media.html

Benzinga · Feb 3, 2022

Blackhawk's MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process

Vancouver, British Columbia - TheNewswire - January 24, 2022 - Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the "Company" or "Blackhawk") is pleased to announce that its subsidiary MindBio Therapeutics Pty Ltd. ("MindBio") has entered into the final stage of a Phase 1 clinical trial involving microdosing LSD and is…

Benzinga · Jan 24, 2022

Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder

Vancouver, British Columbia - TheNewswire - January 17, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the "Corporation" or "Blackhawk") is pleased to announce that its wholly-owned subsidiary MindBio Therapeutics Pty Ltd ("MindBio") is developing a new microdosing formula using LSD (Lysergic Acid Diethylamide) to treat Major Depressive Disorder…

Benzinga · Jan 17, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.